Muscular Dystrophy, Facioscapulohumeral Clinical Trial
— FSHD1Official title:
Exercise and Myopathies. Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients: Functional, Tissue and Quality of Life Benefits.
It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated to physiological and functional positive effects without alteration in quality of life. The review papers from Van der Kooi et al. (2005), Cup et al. (2007) and Féasson et al. (2010) suggest that the combination of endurance and strength training is even more relevant. Only a few controlled and randomized studies have been conducted on this topic. The impact of such training programs on the skeletal muscle regenerative capacities has not been yet addressed. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not regular exercise practice can be maintained in patient's daily life. Also, only a few experiments have reported an integrative view of the potential benefits of such programs on functional, biological and quality of life.
Status | Completed |
Enrollment | 15 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - facioscapulohumeral dystrophy - Being capable of supporting an exercise on ergocycle - Social Security regimen affiliated - Consent form signed Exclusion Criteria: - Severe cardiac or respiratory insufficiency - Cardiac pacemaker - Morbid obesity (BMI upper to 35) - Anti platelet therapy |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
France | CHU de Grenoble | Grenoble | |
France | CHU de Saint-Etienne | Saint-etienne |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Saint Etienne | Association Française contre les Myopathies (AFM), Paris, Örebro University, Sweden |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | maximal oxygen uptake (VO2max) | VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle | Week 24 | No |
Secondary | Questionnaire of quality of life | "short form 36 health survey questionnaire" SF36 | Day 0, Week 6, Week 12, Week 18 and Week 24 | No |
Secondary | Biopsy | biopsy of the vastus lateralis muscle | Day 0 and Week 24 | No |
Secondary | maximal oxygen uptake (VO2max) | VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle | Week 6, Week 12 and Week 18 | No |
Secondary | Questionnaire of subjective fatigue | Fatigue severity scale (FSS) | Day 0, Week 6, Week 12, Week 18 and Week 24 | No |
Secondary | nuclear magnetic resonance imaging | In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images. | Inclusion | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01970735 -
Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2
|
N/A | |
Completed |
NCT02032979 -
Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2
|
N/A | |
Completed |
NCT04154098 -
Evaluation of a Textile Scapula Orthosis
|
N/A | |
Completed |
NCT00004685 -
Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy
|
N/A | |
Recruiting |
NCT06227182 -
Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
|
||
Completed |
NCT01689480 -
Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program.
|
N/A | |
Recruiting |
NCT05747924 -
Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
|
Phase 1/Phase 2 | |
Completed |
NCT04999735 -
Digital Biotyping of FSHD Patients and Controls
|